Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists.
about
Antimigraine drug, zolmitriptan, inhibits high-voltage activated calcium currents in a population of acutely dissociated rat trigeminal sensory neuronsCalcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraineTreatment of migraine attacks based on the interaction with the trigemino-cerebrovascular systemSensitization of central trigeminovascular neurons: blockade by intravenous naproxen infusionThe 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trialsDHE in the pharmacotherapy of migraine: potential for a larger roleOrofacial pain management: current perspectives.Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology.Identification of cytokines and signaling proteins differentially regulated by sumatriptan/naproxen.Migraine: new molecular mechanisms.Responses of dural mast cells in concussive and blast models of mild traumatic brain injury in mice: Potential implications for post-traumatic headache.Neurochemical pathways that converge on thalamic trigeminovascular neurons: potential substrate for modulation of migraine by sleep, food intake, stress and anxietyEffect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial.One hundred years of migraine research: major clinical and scientific observations from 1910 to 2010.Modelling headache and migraine and its pharmacological manipulationTissue injury regulates serotonin 1D receptor expression: implications for the control of migraine and inflammatory painSerotonin and migraine: biology and clinical implications.Finding new drug targets for the treatment of migraine attacks.MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments.Migraine: multiple processes, complex pathophysiology.Subcutaneous delivery of sumatriptan in the treatment of migraine and primary headache.Where do triptans act in the treatment of migraine?Mast cell degranulation activates a pain pathway underlying migraine headache.Migraine, allodynia, sensitisation and all of that ...Migraine treatment throughout the lifecycle.Sumatriptan does not change calcitonin gene-related peptide in the cephalic and extracephalic circulation in healthy volunteersDoes sumatriptan cross the blood-brain barrier in animals and man?Modulation of CGRP-induced light aversion in wild-type mice by a 5-HT(1B/D) agonist.Response properties of dural nociceptors in relation to headache.Experimental migraine models and their relevance in migraine therapy.Sumatriptan: update and review.Triptans disrupt brain networks and promote stress-induced CSD-like responses in cortical and subcortical areas.The complex actions of sumatriptan on rat dural afferentsCentral sensitization theory of migraine: clinical implications.Calcitonin gene-related peptide enhances release of native brain-derived neurotrophic factor from trigeminal ganglion neurons.New migraine and pain research.Vascular extracellular signal-regulated kinase mediates migraine-related sensitization of meningeal nociceptors.Sensitization of meningeal nociceptors: inhibition by naproxen.Serotonin type 1D receptors (5HTR) are differentially distributed in nerve fibres innervating craniofacial tissues.The blood-brain barrier in migraine treatment.
P2860
Q21093203-2316CEFA-3BBC-4813-B11F-1E4047E9C5CAQ24632671-140EA683-5FF4-4146-AF01-19D81362B555Q24646305-63E578D8-8CA7-4646-8875-DAEDD40AB3BFQ24648979-A1A27DCC-EBDE-4471-A75D-EB035157BC4BQ26829564-789C97FF-9D27-44B8-9FC5-436554B26A24Q28271614-428E9F1F-C78C-402F-B83A-0525F09637EAQ30442178-B7F8EDE0-B406-49F8-834B-CF5A6FC2E3D8Q30465785-1B5702B4-7415-4634-9C71-C5A19633447EQ30505261-8D683AAA-1CA8-4EE5-9454-7C2ED648DD60Q33220839-980E866B-7492-4AD7-8FA1-A71D8D89E0DEQ33882320-BBE81AF3-D8DF-4332-9190-2CFC8A2E7B1BQ34000048-48E57906-44E9-42D1-A04D-00A7276592EDQ34164195-293B2A4B-45E4-4B55-9DB8-37A2FFE32B8FQ34180539-62D33122-9EED-498A-B57A-2FA57DC4EDBEQ34407137-2F22B0A1-85B4-4D04-881A-732447196A1FQ34555809-C5E0BD4E-73A2-4FC8-ABF5-AE1A97960E2CQ34655338-E8955D41-8F05-44B6-93F3-85C2713C2887Q34954050-EB25800C-ADAC-4696-B91C-AF342088DFE6Q35248055-7CE1597C-B036-4CA1-957D-F3BD5525C61FQ35547845-BBD5C0A5-C86E-4AD7-8235-37E9ADD30D79Q35684215-FC6C4063-80B8-49F7-8789-34F42EDC1BA4Q35748273-45103073-5639-4B73-B4FE-C307B7B61D9BQ36098310-B156F95B-2500-4E35-B7B7-7826206DCEC4Q36141468-7D6D7053-149C-41F2-8FEC-A7B9DD721850Q36153372-C303788F-57E3-466B-A023-62454DB40906Q36259595-73221E5B-D3D8-4180-8277-035B3FC4898AQ36260908-DD2FA290-43BF-4619-8697-B0D86CB95066Q36401525-C09929A1-1A9D-4024-996C-7FF32192A69FQ36403060-A93C50D2-AE6B-448D-892C-2B678764DE5AQ36474260-B6D56984-F006-4D6D-B9BE-3450117988DFQ36543148-E8020B2F-6982-483C-AC81-56A62572D790Q36598107-F8D56438-2FB0-464C-AC53-7794C710B7AAQ36641373-97223ADE-0B49-42CA-BD9E-AB2AAADF9DE1Q36641567-EEBC5790-5D47-4B56-8DF6-38E642E52F5AQ36737699-CF747B30-0F47-41F8-8BC1-4B1645AEE589Q36787453-62F0F334-AE77-4FBE-888C-65806A27FA4AQ36944819-571B937A-88E7-4F9A-9B36-C8A8511886F0Q37181373-DCC14CB6-0FBD-4F58-B5B8-42272C4D708FQ37192862-1BEE13EC-04FF-4D18-996E-AAC7B0D94AA1Q37252452-36C42B8A-EF22-4243-8B2E-65027A8C87FB
P2860
Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 March 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Disruption of communication be ...... f 5HT 1B/1D receptor agonists.
@en
Disruption of communication be ...... f 5HT 1B/1D receptor agonists.
@nl
type
label
Disruption of communication be ...... f 5HT 1B/1D receptor agonists.
@en
Disruption of communication be ...... f 5HT 1B/1D receptor agonists.
@nl
prefLabel
Disruption of communication be ...... f 5HT 1B/1D receptor agonists.
@en
Disruption of communication be ...... f 5HT 1B/1D receptor agonists.
@nl
P2860
P356
P1476
Disruption of communication be ...... f 5HT 1B/1D receptor agonists.
@en
P2093
Moshe Jakubowski
P2860
P304
P356
10.1073/PNAS.0306147101
P407
P577
2004-03-11T00:00:00Z